Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Barbara
Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Impact of local treatment on survival outcomes in patients with metastatic lung cancer with oligoprogression undergoing immunotherapy
Skip to main navigation menu Skip to main content Skip to site footer DOI: https://doi.org/10.57187/4790 Original article Vol. 156 No. 4 (2026) Cite this as: Swiss Med Wkly. 2026;156:4790 Published 27.04.2026 PURPOSE: Immune checkpoint inhibitors have revolutionised the management of non-small cell lung cancer (NSCLC) without oncogenic addictions and have improved its prognosis.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Barbara
Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack